
Dr Lal PathLabs Franchise
Revenue-share collection-centre franchise of listed Dr Lal PathLabs: about ₹3–4 L, 200–250 sq ft; 7,727 patient service centres (Mar 2026).
Dr Lal PathLabs franchise at a glance (terms checked Sept 2026)
Investment
₹3 L - ₹4 L
Below the category (typical ₹14.5 L–₹33.44 L, median ₹21.43 L, 8 verified brands)
Ongoing take
Not published
Franchise fee
Not published
Payback
about 20–40 months*
* Not verified — the brand doesn't publish this; the figure comes from other published sources or FranchiseChuno's estimate (see "Reported elsewhere" and "Our estimates" below). Real numbers can differ.
- Legal or regulatory action on record — see Reputation & News
- Disputes with franchisees: None found (records checked Sep 2026)
- Profit or loss: Profit of ₹509.8 Cr in FY26
- Company standing: Active and up to date with the registrar
Franchisor strength isn't franchisee profit — check real outlet numbers.
Outlets
7,727 (brand claim)
What we couldn't verify
- • Outlet closures
- • Franchisee satisfaction
- • Outlet claim matches reality
- • Ongoing take
Ask before you sign
- Speak to at least 3 franchisees who have run an outlet for 2+ years and see their actual monthly sales and profit — a franchisor making money doesn't mean its franchisees do.
- Ask for the one-time franchise fee in writing, and whether any part is refundable.
- Ask for the royalty and any marketing-fund fee, and how they're calculated (on sales or profit).
Franchise terms checked against Dr Lal PathLabs's official franchise page on 27 Sept 2026. Figures marked * aren't published by the brand — they come from other published sources or our own estimate, and aren't verified.
Ways to Partner with Dr Lal PathLabs
1 partner model published by the brand. Figures it doesn't publish are left blank.
Collection centre (PSC)
- Investment
- ₹3 L – ₹4 L
- Space
- 200 sq ft – 250 sq ft
- Royalty / margin
- Revenue share: the company books the test revenue and pays the franchisee its share monthly (rate not published)
- Who it suits
- A self-motivated entrepreneur; medical background preferred
Exclusive Dr Lal PathLabs collection centre; samples go to the company's labs for testing.
Our Estimates
FranchiseChuno estimateDr Lal PathLabs doesn't publish these, so here is our best read of the market and how we got there. They are our estimates, not the brand's figures — use them to plan, then confirm the real numbers in writing.
Collection centre's share of test revenue
about 20–30% of billed tests*
Dr Lal PathLabs doesn't publish the share. Its FY26 accounts show ₹402.4 Cr paid to collection centres and channel partners — 14.6% of consolidated revenue from operations (₹2,762.9 Cr), which also includes its own labs, home collection and B2B work that pay no franchise share. The share on tests booked at a franchised centre is therefore well above 14.6%; we put it at about 20–30%. Confirm the actual rate in the agreement.
Analyst judgement · Sep 2026
Average payout per collection centre
~₹30,000–45,000 a month*
₹402.4 Cr of FY26 fees spread over 7,727 PSCs is about ₹43,000 a month per centre if PSCs received all of it (FY25: ₹341.9 Cr over 6,607 PSCs, also about ₹43,000); some goes to pick-up-point partners, so the typical centre likely earns less — about ₹30,000–45,000 a month before its own rent and staff. Centres vary widely with footfall.
Unit-economics model · Sep 2026
Payback on a ₹3–4 L collection centre
about 20–40 months*
Taking ₹30,000–45,000 a month of revenue share, less roughly ₹20,000–30,000 for a small ground-floor rent and one phlebotomist/front-desk staffer, leaves about ₹10,000–15,000 a month in a middle case; that recovers ₹3–4 L in roughly 20–40 months (₹3 L ÷ ₹15,000 = 20; ₹4 L ÷ ₹10,000 = 40). A centre with low footfall and high rent may not pay back at all.
Unit-economics model · Sep 2026
Unit Economics
Mixed sourcesHow Dr Lal PathLabs says an outlet's numbers work. These are illustrations, not guarantees — check them against existing franchisees before you sign.
Collection centre (PSC)
- Fees paid to all collection centres and channel partners, network-wideConsolidated expense line — the total the company paid out to collection centres and channel partners, about 14.6% of revenue from operations (₹2,762.9 Cr). It is not a per-centre figure and includes pick-up-point partners.
- 4,02,39,90,000 INR
- Fees paid to all collection centres and channel partners, network-wideConsolidated expense line — the total the company paid out to collection centres and channel partners, about 13.9% of revenue from operations (₹2,461.4 Cr). It is not a per-centre figure and includes pick-up-point partners.
- 3,41,65,90,000 INR
Reputation & News
4 red flags to checkWhat the press, courts and real franchisees or customers have said about Dr Lal PathLabs — summarised by us, with every source linked.
- Legal / regulatory· Jun 2025
Consumer commission upholds ₹3.5 L compensation over a wrong test report
The Delhi State Consumer Disputes Redressal Commission dismissed Dr Lal PathLabs's appeal and upheld ₹3.5 L compensation to a patient whose urea report wrongly showed dangerously high levels, leading to emergency care. The original award dated from August 2014; the appeal ruling came in May 2025.
Source: LawChakra - In the news· Nov 2015
IPO prospectus flagged allegations against a Jalandhar franchisee
In its Nov 2015 prospectus the company disclosed press reports alleging that a franchisee in Jalandhar swapped blood samples to match donor and recipient DNA reports for kidney transplants; it said the allegations were unconfirmed and no investigation had been started against the company. The same document disclosed a 2015 Odisha police (Special Task Force) inquiry into alleged illegal kidney transplants linked to tests done at its laboratory, in which documents were seized; it said no further communication had followed.
Source: Dr Lal PathLabs red herring prospectus (SEBI), Nov 2015 - Legal / regulatory· Jul 2013
Chandigarh commission upholds compensation over wrong allergy report
The Chandigarh State Consumer Commission dismissed Dr Lal PathLabs's appeal in 2013 and upheld ₹50,000 compensation to a patient whose test report wrongly indicated a wheat allergy.
Source: Indian Kanoon — State Consumer Commission, UT Chandigarh - In the news· Oct 2020
TechCrunch: patient data left on an unsecured cloud server
TechCrunch reported in Oct 2020 that Dr Lal PathLabs had stored spreadsheets of patient bookings — names, addresses, phone numbers and the tests booked, some with COVID-19 remarks — in a cloud storage bucket without a password. A security researcher said it held millions of bookings; the company shut access after being told and said it was investigating.
Source: TechCrunch
Show 2 moreShow fewer
- In the news· Jul 2026
Q1 FY27 call: more labs, radiology pilots and a Ghana acquisition
On the July 2026 earnings call, CEO Shankha Banerjee said the company plans to add 12–15 labs in FY27 and 3–4 radiology centres. Management guided revenue growth towards the mid-teens and announced an 80% stake purchase in Sunshine Healthcare, Ghana.
Source: Investing.com (earnings call transcript) - In the news· Feb 2024
CARE Ratings cites franchisee network and market position
CARE Ratings' press release lists the company's leading position, strong brand and franchisee model among its rating strengths. It also notes 277 labs, 5,102 PSCs and 10,938 pick-up points as of March 2023, and B2C revenue staying above 70% of sales.
Source: CARE Ratings
Sales by region, FY23
| Region | Share of sales |
|---|---|
| North | 62% |
| West | 16% |
| East | 14% |
| South | 6% |
Key Terms at Dr Lal PathLabs
The clauses that shape day-to-day running and your exit — read these before the fee.
- Payments to the brand
- Collection-centre franchises run on a revenue share: the company records the centre's gross test revenue and pays the franchisee its specified share monthly (IPO prospectus, 2015). The share isn't published.
- Renewal
- Collection-centre agreements are exclusive and typically run five to nine years (IPO prospectus, 2015).
- Non-compete
- Franchisees may not do pathology tests or related work themselves or with third parties during the agreement and for two years after it ends (IPO prospectus, 2015).
- Who pays for what
- The franchisee finds the premises, provides basic diagnostic equipment and, in some cases, hires phlebotomists and front-office staff; the company gives technical, personnel and marketing support and sometimes supplies consumables (IPO prospectus, 2015).
- Other terms
- Two partner agreements seen in Delhi High Court orders send disputes to a sole arbitrator in Delhi: a 2015 revenue-sharing agreement names Delhi as the venue, and a 2016 sample-collection MoU names New Delhi as the place of arbitration. Neither is shown to be a collection-centre franchise agreement; the company doesn't publish its current franchise contract.
Legal & Contract Summary
Key contract terms at a glance — read before you sign.
Agreement Type
Not specifiedContract Duration
—Renewal Available
—Territory Exclusivity
—Non-Compete Clause
—Exit Clause
—Who Can Apply for Dr Lal PathLabs
Conditions the brand sets for partners, and the licences the business needs.
- Premises: About 200–250 sq ft on the ground floor with a toiletRequired
- Background: Medical background preferredPreferred
- Profile: A self-motivated entrepreneurRequired
About the Brand
Brand USP
Samples collected at your centre go to Dr Lal PathLabs's own network of 312 clinical labs, 53 of them NABL-accredited (FY26 annual report).
Why invest in Dr Lal PathLabs?
Dr Lal PathLabs by the Numbers
Source marked on each figure1949, Delhi
Founded
Brand claim312
Clinical labs · Mar 2026
Company filing7,727
Patient service centres · Mar 2026
Company filing13,935
Pick-up points · Mar 2026
Company filing53
NABL-accredited labs · Mar 2026
Company filing28
Countries of operation · Sep 2026
Brand claim30.3 million in FY26
Patients served · Mar 2026
Company filingDecember 2015
Listed since
Company filingDr Lal PathLabs Outlet Network
Outlet count over time
- Mar 20213,705
FY21 · media.lalpathlabs.com
- Mar 20224,731
FY22 · media.lalpathlabs.com
- Mar 20235,102
FY23 · media.lalpathlabs.com
- Mar 20245,762
FY24 · media.lalpathlabs.com
- Mar 20256,607
FY25 · media.lalpathlabs.com
- Mar 20267,727
FY26 · media.lalpathlabs.com
- Mar 2013776
FY13 PSCs · sebi.gov.in
- Mar 201348
FY13 PSCs · sebi.gov.in
- Mar 20141,009
FY14 PSCs · sebi.gov.in
- Mar 201455
FY14 PSCs · sebi.gov.in
- Mar 20151,271
FY15 PSCs · sebi.gov.in
- Mar 201569
FY15 PSCs · sebi.gov.in
- Sep 20151,475
Sep 2015 PSCs · sebi.gov.in
- Sep 201579
Sep 2015 PSCs · sebi.gov.in
These counts come from different sources — brand claims, press reports and store locators — so they aren't a like-for-like series. Treat the brand's own claims as the upper end.
Cities with Outlets
Show all 55 citiesHide the city list
Company Financials
Brand-level, publicly reportedThe franchisor's own company health — separate from what a single franchise outlet earns.
Revenue (FY26)
₹2864.18 Cr
Net profit (FY26)
₹509.75 Cr
Total funding raised
$13.9M+
Employees (May 2026)
5,205
Notable investors
Source: Dr Lal PathLabs annual report 2025-26 — audited consolidated total income and profit
Source: Tracxn — Dr Lal PathLabs, funding and headcount (Sep 2026)
A profitable franchisor doesn't mean profitable franchisees. These are the company's numbers, not an outlet's. A franchisor can grow on fees and supplies while outlets struggle — talk to existing franchisees and see their accounts before you decide.
Company Health Check
What Dr Lal PathLabs's franchisor company has filed with the registrar and the courts — the checks a lawyer would run before you sign.
- Status with the registrar
- Active
- Annual filings
- Up to date
- Last AGM
- 25 Jul 2026
- Paid-up capital
- ₹167.55 Cr
- Auditor
- Deloitte Haskins & Sells LLP
Group companies
- Paliwal Diagnostics Pvt LtdSubsidiary · 80%
- Chanre Laboratory Pvt LtdSubsidiary · 70%
- Pathlabs Unifiers Pvt LtdSubsidiary · 100%
- Dr. Lal Ventures Pvt LtdSubsidiary · 100%
- Centrapath Labs Pvt LtdSubsidiary · 70%
- APRL Pathlabs Pvt LtdSubsidiary · 80%
Source: FY26 annual report (borrowings nil at 31 Mar 2026, consolidated; paid-up capital after the Dec 2025 1:1 bonus issue; CARE issuer rating upgraded 25 Mar 2026; 32nd AGM held 25 Jul 2026); Tracxn — MCA master data (Active, compliant as of 13 Dec 2025; 3 registered charges totalling ₹225.06 Cr on the MCA register, which are not drawn debt) (checked Jul 2026)
Full company recordsFinancials year by year, registered details, leadership and timelineShowHide
Dr Lal PathLabs Financials Over Time
Figures for the brand, from filed or reported accounts.
Source: Tracxn — Dr. Lal PathLabs Ltd filings · Tracxn — Dr. Lal PathLabs Ltd filings; EBITDA from the FY26 annual report's financial highlights · Dr Lal PathLabs annual report 2025-26
A profitable franchisor doesn't mean profitable franchisees. These are the company's numbers, not an outlet's. A franchisor can grow on fees and supplies while outlets struggle — talk to existing franchisees and see their accounts before you decide.
Company Profile
The legal entity behind the brand, its leadership, and its official channels.
- Registered name
- Dr. Lal PathLabs Limited
- Company type
- Public Listed
- CIN
- L74899DL1995PLC065388
- Incorporated
- 14 Feb 1995
- Headquarters
- Delhi
Leadership
- DDr. Arvind LalExecutive Chairman
- SShankha BanerjeeCEO
- VVed Prakash GoelGroup CFO and CEO, International Business
Social presence
Company details source: Tracxn — company filings
Dr Lal PathLabs Timeline
1949
Founded
Dr. (Major) S.K. Lal starts pathology services and a blood bank in Delhi.
1982
Collection-centre franchising begins
The company says it began franchising collection centres in 1982.
1995
Incorporated
Incorporated as Dr Lal PathLabs Private Ltd.
2000
NABL accreditation
Hanuman Road lab in Delhi receives NABL accreditation.
2002
CAP accreditation
Hanuman Road lab receives international accreditation from CAP.
2005
WestBridge Capital invests
Private equity investment by WestBridge Capital.
2008
Paliwal acquisition
Acquires Paliwal Medicare and Paliwal Diagnostics.
2010
National Reference Lab
National Reference Lab set up in Delhi.
Dec 2015
IPO
Shares listed on the stock exchanges.
2018
Kolkata reference lab
Regional Reference Lab commissioned in Kolkata.
FY22
Suburban Diagnostics acquired
Acquires Suburban Diagnostics to strengthen presence in western India.
SourceMar 2026
Credit rating upgraded
CARE Ratings upgrades the issuer rating to CARE AA+; Stable from CARE AA; Stable.
Jul 2026
Ghana acquisition approved
Board approves buying 80% of Sunshine Healthcare Limited, Ghana, and 30% of Neuome Technologies.
SourceFY27Announced plan
Plan: 12–15 new labs and 3–4 radiology centres
Stated by management on the Q1 FY27 earnings call (Jul 2026).
Source
FranchiseChuno Analysis
Our analysis of verified dataHow Dr Lal PathLabs looks once the numbers are checked side by side.
- •Investment below the Healthcare & Pharmacy medianMidpoint ₹3.5 L vs a category median of ₹21.4 L across brands on FranchiseChuno.
- ✓The franchisor company is profitableIts latest filed accounts show a net profit. That's the franchisor's money, not yours: a profitable franchisor doesn't mean its franchisees make money. Check real outlet numbers before you invest.
- ✓44 years of franchisingFranchising since 1982, with 7,727 outlets.
- !3 red flags in the news or public discussionSee Reputation & News below, and ask the brand to address each one.
Data completeness
55%
- ✓ Terms checked against the brand's own page
- ✓ Published investment (not an estimate)
- ○ Franchise fee
- ○ Royalty
- ○ ROI or payback claim
- ○ Agreement term
- ○ Training details
- ✓ Outlet cities verified
- ✓ Company financials
- ✓ Legal entity
- ✓ News & public opinion checked
Ask Before You Sign
Questions tailored to what Dr Lal PathLabs does and doesn't publish.
- 1Speak to at least 3 franchisees who have run an outlet for 2+ years and see their actual monthly sales and profit — a franchisor making money doesn't mean its franchisees do.
- 2Ask for the one-time franchise fee in writing, and whether any part is refundable.
- 3Ask for the royalty and any marketing-fund fee, and how they're calculated (on sales or profit).
- 4Ask for the agreement term, renewal fee and exit or transfer terms.
- 5Ask whether you get an exclusive territory, and how large it is.
- 6Ask the brand to respond to each red flag listed under Reputation & News.
- 7Have a lawyer review the franchise agreement before paying anything.
- 8Visit 2–3 existing outlets and speak to their owners without the brand present.
Running the outletSpace, staff, launch steps, training, support and who does whatShowHide
Operations Required
What you'll need on the ground to run this franchise day-to-day.
Area Required
200 - 250 sq ft
Staff Needed
—
Setup Time
—
Owner Involvement
—
Best Locations
Not published
Business Type
Not published
Training & Support
What the brand provides to help you launch and run your franchise.
Operations Manual
Step-by-step playbook for running the outlet
Supply Chain Support
Vendor sourcing, inventory & logistics
Technology / POS
Billing, inventory, and management software
Marketing Support
National & local marketing campaigns
Launch Support
Pre-opening setup and grand-opening assistance
Ongoing Field Support
Regular visits and operational coaching
What Dr Lal PathLabs franchisees say
We haven't yet heard from enough Dr Lal PathLabs franchisees to show anything. We publish totals once 3 or more people who run an outlet have answered and we've called each one to check.
I run a Dr Lal PathLabs outlet — share how it wentFrequently Asked Questions
What is the total investment for a Dr Lal PathLabs franchise?
How does a Dr Lal PathLabs collection centre earn money?
How long is a Dr Lal PathLabs franchise agreement, and can I work with another lab after I leave?
Who pays for equipment and staff at a Dr Lal PathLabs collection centre?
How much does Dr Lal PathLabs pay its collection centres in total?
How are disputes with Dr Lal PathLabs resolved?
Similar Healthcare & Pharmacy Franchises
View AllInterested in
Dr Lal PathLabs


